NovoCure Limited (NasdaqGS: NVCR)
Health Care · Health Care Equipment & Supplies · CH
$17.21
+0.64% today · +46.2% 1Y
NovoCure Limited (NasdaqGS: NVCR) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.99B and employs 1,605 people.
Over the last twelve months the share price has gained 46.2%, trading between 9.82 and 21.45.
Tweenvest scores NovoCure Limited across four factors: quality 54/100, value 64/100, growth 58/100. Its strongest factor is value.
NVCR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.99B
- Revenue (TTM)
- $699.19M
- P/E
- —
- EPS
- -1.31
- Dividend yield
- —
- Beta (5Y)
- 0.98
- 52-week high
- $21.45
- 52-week low
- $9.82
- Avg volume (3M)
- —
- Shares outstanding
- 116.45M
- Employees
- 1,605
- Next earnings
- —
About NovoCure Limited
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
- ISIN
- JE00BYSS4X48
- Founded
- 2000
- Listed since
- Oct 2, 2015
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.55 | -0.50% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.13 | -0.19% |
| Stryker CorporationNYSE: SYK | $126.81B | $333.03 | +0.74% |
| Medtronic plcNYSE: MDT | $116.66B | $91.59 | +0.49% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.77 | -4.19% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $91.77 | +0.99% |
Figures last refreshed Aug 18, 2026.